Alemnew F. Dagnew

Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in adults with haematological malignancies: a phase 3, randomised, clinical trial and post-hoc efficacy analysis

Alemnew F. Dagnew, Osman İlhan, Won Sik Lee et al. · The Lancet Infectious Diseases · 2019 · 242 citations

Vaccination, Vaccine Safety, Vaccinology +11

Medical conditions at enrollment do not impact efficacy and safety of the adjuvanted recombinant zoster vaccine: a pooled post-hoc analysis of two parallel randomized trials

Lidia Oostvogels, Thomas C. Heineman, Robert W. Johnson et al. · Human Vaccines & Immunotherapeutics · 2019 · 47 citations · Full text

Vaccination, Vaccinology, Cross-protection +15

Diagnosis of latent tuberculosis infection in healthy young adults in a country with high tuberculosis burden and BCG vaccination at birth

Alemnew F. Dagnew, Jemal Hussein, Markos Abebe et al. · BMC Research Notes · 2012 · 36 citations · Full text

Adjuvanted recombinant zoster vaccine in adult autologous stem cell transplant recipients: polyfunctional immune responses and lessons for clinical practice

Edward A. Stadtmauer, Keith M. Sullivan, Mohamed El Idrissi et al. · Human Vaccines & Immunotherapeutics · 2021 · 33 citations · Full text

Non-inferiority of mammalian cell-derived quadrivalent subunit influenza virus vaccines compared to trivalent subunit influenza virus vaccines in healthy children: a phase III randomized, multicenter, double-blind clinical trial

Robyn Hartvickson, Marilou Cruz, John Ervin et al. · International Journal of Infectious Diseases · 2015 · 32 citations · Full text